Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
mtruong34's Profile
Displaying 201-250 of 505 result(s).
CYDY CytoDyn Inc
01/15/2021 7:25:23 PM
Correct me if I'm wrong. Reading to (1)
CYDY CytoDyn Inc
01/15/2021 5:00:59 PM
Sounds like its worth $10 a share t (2)
CYDY CytoDyn Inc
01/15/2021 4:48:11 PM
To me, it means Fife thinks the sto (3)
CYDY CytoDyn Inc
01/15/2021 4:39:06 PM
New S3 http://archive.fast-edgar.co
CYDY CytoDyn Inc
01/15/2021 12:07:39 PM
Dr. Agresti providing instructions (10)
CYDY CytoDyn Inc
01/14/2021 2:49:57 PM
There were a couple of posters on Y (8)
CYDY CytoDyn Inc
01/14/2021 11:02:37 AM
Would Cytodyn be subject to these n
CYDY CytoDyn Inc
01/13/2021 9:27:32 PM
Unbelievable. This review totally i
CYDY CytoDyn Inc
01/13/2021 6:07:29 PM
Another failed ph3 s/c study. We ca (6)
CYDY CytoDyn Inc
01/13/2021 2:40:24 PM
What p value is typically associate
CYDY CytoDyn Inc
01/13/2021 2:01:12 PM
If I was a patient in the trial I w
CYDY CytoDyn Inc
01/13/2021 12:28:40 PM
Reposting some useful information f (16)
CYDY CytoDyn Inc
01/13/2021 2:19:14 AM
Leronlimab mentioned for HIV. https
CYDY CytoDyn Inc
01/13/2021 2:13:38 AM
Regarding biology or chemistry, mol
CYDY CytoDyn Inc
01/12/2021 11:01:36 PM
https://www.youtube.com/watch?v=BI (3)
CYDY CytoDyn Inc
01/12/2021 9:19:29 PM
Pre-print study with references to (6)
CYDY CytoDyn Inc
01/12/2021 5:35:14 PM
Dec. 24 PR has the more up to date (2)
CYDY CytoDyn Inc
01/12/2021 4:12:35 PM
I can agree in terms of dosing, RO
CYDY CytoDyn Inc
01/12/2021 3:48:39 PM
But now you have to add back in the
CYDY CytoDyn Inc
01/12/2021 3:25:41 PM
I'm thinking in the end it will end
CYDY CytoDyn Inc
01/12/2021 3:23:53 PM
I would like to add: d) DSMC at 50% (3)
CYDY CytoDyn Inc
01/12/2021 10:21:50 AM
Re-reading Dr. Yang's paper clearly (2)
CYDY CytoDyn Inc
01/11/2021 9:24:25 PM
Thanks for that info Ohm. My origin (1)
CYDY CytoDyn Inc
01/11/2021 8:41:02 PM
I think during normal times that wo (1)
CYDY CytoDyn Inc
01/11/2021 7:52:45 PM
MAV used a mortality rate from Ohm' (1)
CYDY CytoDyn Inc
01/11/2021 6:23:23 PM
Your math assumes everyone in the C (3)
CYDY CytoDyn Inc
01/11/2021 3:51:29 PM
@Doctor580. Just to be clear, no on (1)
CYDY CytoDyn Inc
01/11/2021 12:54:37 PM
100% agreement here. If you can rec (6)
CYDY CytoDyn Inc
01/10/2021 8:42:43 PM
Exactly! Thank you! All these guys (2)
CYDY CytoDyn Inc
01/10/2021 2:26:09 AM
Calstang, I believe there is still
CYDY CytoDyn Inc
01/10/2021 2:22:59 AM
Research Letter Open Access Publish (3)
CYDY CytoDyn Inc
01/09/2021 11:19:22 PM
My example was for cd12 s/c 50% int
CYDY CytoDyn Inc
01/09/2021 6:14:25 PM
You are setting unrealistic expecta (2)
CYDY CytoDyn Inc
01/09/2021 3:24:41 PM
Excellent work NuGilead on the time (3)
CYDY CytoDyn Inc
01/08/2021 5:07:50 PM
Possibly some MM shenanigan to let
CYDY CytoDyn Inc
01/08/2021 2:01:23 PM
Me too. Just bought another 1500 sh (1)
CYDY CytoDyn Inc
01/08/2021 12:40:03 PM
I don't think OLE gets added to the (3)
CYDY CytoDyn Inc
01/08/2021 11:08:16 AM
Totally worth it to get uplisting I
CYDY CytoDyn Inc
01/08/2021 10:52:43 AM
I'm with you on this one. Rushing t (2)
CYDY CytoDyn Inc
01/08/2021 10:42:30 AM
I believe NP said it was due Januar (1)
CYDY CytoDyn Inc
01/08/2021 10:40:27 AM
My theory is that they are rushing (3)
CYDY CytoDyn Inc
01/08/2021 10:35:00 AM
Sharing cost analysis by username B (13)
CYDY CytoDyn Inc
01/07/2021 3:17:27 PM
Thanks for the additional insights. (3)
CYDY CytoDyn Inc
01/07/2021 2:28:01 PM
Will 25% reduction in deaths be the (1)
CYDY CytoDyn Inc
01/07/2021 10:11:13 AM
No. I did not submit that question (1)
CYDY CytoDyn Inc
01/07/2021 2:53:03 AM
Thomas Landstreet ranting about Ler (14)
CYDY CytoDyn Inc
01/07/2021 2:25:45 AM
I think CI has a legit point. The s (2)
CYDY CytoDyn Inc
01/07/2021 1:05:19 AM
I think CI believes there is a dist (1)
CYDY CytoDyn Inc
01/06/2021 10:34:57 PM
Again, as explained earlier. I'm no (2)
CYDY CytoDyn Inc
01/06/2021 10:25:31 PM
OK. I think we are talking about tw (2)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • DTE Energy's Robust Financial Performance and Future Plans
  • Evogene Ltd Plans to Release Q2 Financial Results Soon
  • F24 Launches Advanced Risk Monitoring Solution for Companies
  • Atossa Therapeutics Takes Significant Steps in Breast Cancer Treatment
  • Jacobs Enhances Passenger Experience at Denver Airport
  • Commvault Reports Impressive First Quarter Victories
  • Elevating Community Banking: West Cary Group Partners with ABNB
  • Activists Unite in Dakar to Demand France Address Colonial Wrongs
  • Industrial Coatings Surge: Growth Projections and Market Trends
  • BYD Rises in Fortune Global 500 Hitting New Milestones
  • Understanding the S&P 500 Concentration and Its Impact
  • Repligen Continues Strong Growth in 2025 Financials
  • UnitedHealth Group's Latest Earnings Report and Growth Outlook
  • Exciting Business Update Call from SIGA Technologies Soon
  • Kiniksa Pharmaceuticals Demonstrates Strong Growth in 2025Q2
  • Qualcomm's Upcoming Earnings: Market Expectations and Insights
  • Quipt Home Medical Corporation's Upcoming Financial Call Event
  • Iveco Group Explores New Opportunities for Defence Business
  • Industrial Coatings Market Projected to Reach $142.35 Billion
  • Datavault AI Expands AI-Driven Data Solutions for Enterprises
  • BriaPro's Patent Application Signals a Breakthrough in Cancer Treatment
  • Digital Asset Technologies Invites Investment in Future Finance
  • Cognition Therapeutics Unveils Key Findings on CT1812 at AAIC
  • Quipt Home Medical Corp. to Share Q3 2025 Financial Insights
  • SIGA Technologies Plans Business Update Call and Highlights
  • HTX Launches Unique Code Feature with Bitcoin Prize Offer
  • Brixton Metals Delivers Promising Drill Results in Thorn Project
  • Allianz Life's Cybersecurity Breach: What You Need to Know
  • Bitmain's Strategic Move to Launch US Operations in Crypto Mining
  • Lassonde Industries Prepares for CFO Transition in Leadership
  • Exciting Developments from Dragonfly Energy's Latest Results
  • Discover Top Industrials Stocks Set to Surge This Quarter
  • Fidelity Investments Launches Exciting New ETF for Income Boost
  • Radiopharm Theranostics Achieves Key Milestones in 2025
  • BriaPro Unveils Innovative Patent for Cancer Immunotherapy Agents
  • TVA's Financial Highlights and Future Energy Initiatives
  • Cognition Therapeutics Showcases Zervimesine's Promise in Dementia
  • ZOOZ Launches Major Bitcoin Treasury Strategy with $180M Placement
  • SECURE Waste Infrastructure Reports Strong Q2 2025 Performance
  • Novo Nordisk Welcomes Maziar Mike Doustdar as New CEO
  • Lassonde Industries Announces CFO Transition and Future Plans
  • PayPal's Stellar Q2 2025 Financial Highlights Unveiled
  • uniQure's Q2 2025 Financial Report: Milestones and Future Vision
  • ArisGlobal's Innovative Growth and Momentum in Life Sciences
  • Norfolk Southern's Strong Q2 Results and Future Outlook
  • ProLift Garage Doors of Humble Launches Annual School Supply Drive
  • Understanding Bandwidth Inc.'s Latest Financial Performance
  • Exploring New Horizons: Journey Partners with Starlab Team
  • Repligen Corporation Shows Strong Growth and Financial Outlook
  • Richard Soloway Honored as Security Innovator for 2025 by NAPCO
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site